Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Personalized Cancer Treatment Global Market Report 2025
Request Sample Buy Now
Global Personalized Cancer Treatment Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Personalized Cancer Treatment Global Market Report 2025

By Treatment Type (Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type), By Diagnostic Techniques (Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types), By End-Users (Hospitals And Clinics, Research Institutes, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Personalized Cancer Treatment Market Overview

• Personalized Cancer Treatment market size has reached to $181.55 billion in 2024

• Expected to grow to $301.14 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%

• Growth Driver: Surge In Cancer Prevalence Fuels Expansion Of Personalized Cancer Treatment Market

• Market Trend: AI-Driven Analytics Revolutionizing Personalized Cancer Treatment

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Personalized Cancer Treatment Market?

Personalized cancer treatment customizes therapies based on an individual's unique genetic profile and tumor characteristics, to achieve more effective and targeted interventions. This approach enhances treatment plans and improves patient outcomes by examining genetic mutations and biomarkers, compared to traditional one-size-fits-all methods.

The main types of personalized cancer treatment include targeted therapy, immunotherapy, hormone therapy, chemotherapy, radiation therapy, and others. Targeted therapy uses drugs or other substances to precisely identify and attack cancer cells without harming normal cells. Diagnostic techniques such as genomic sequencing, liquid biopsy, immunohistochemistry, in situ hybridization, biomarker testing, and other diagnostic techniques are used for cancer types including breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, and others, and are used by end-users including hospitals and clinics; research institutes; others

Personalized Cancer Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Personalized Cancer Treatment Market Size 2025 And Growth Rate?

The personalized cancer treatment market size has grown rapidly in recent years. It will grow from $181.55 billion in 2024 to $200.98 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to advancements in genomics and molecular biology, increasing prevalence of cancer, a rise in personalized medicine adoption, growing awareness about cancer treatment options, and improved cancer diagnostics and monitoring technologies.

What Is The Personalized Cancer Treatment Market Growth Forecast?

The personalized cancer treatment market size is expected to see rapid growth in the next few years. It will grow to $301.14 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to the expansion of targeted therapies, advancements in AI and machine learning for treatment planning, increasing investment in cancer research, growing demand for precision medicine, and the development of new biomarkers for personalized treatments. Major trends in the forecast period include the rising use of combination therapies, increased integration of digital health tools, growth in the adoption of liquid biopsy techniques, expansion of immunotherapy options, and enhanced focus on patient-centric care models.

The forecast of 10.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. oncology sector by increasing the cost of next-generation sequencing panels and CAR-T cell therapy components sourced from Switzerland and Singapore, thereby delaying precision medicine adoption and elevating cancer center expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Personalized Cancer Treatment Market Segmented?

1) By Treatment Type: Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type

2) By Diagnostic Techniques: Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types

4) By End-Users: Hospitals And Clinics, Research Institutes, Other End Users

Subsegments:

1) By Targeted Therapy: Monoclonal Antibodies, Small Molecule Inhibitors, Angiogenesis Inhibitors, Signal Transduction Inhibitors

2) By Immunotherapy: checkpoint inhibitors, CAR T-Cell Therapy, Cancer Vaccines, Monoclonal Antibodies For Immunotherapy

3) By Hormone Therapy: Anti-Estrogens, Aromatase Inhibitors, Progestins, LHRH Agonists

4) By Chemotherapy: Alkylating Agents, Antimetabolites, Anthracyclines, Taxanes

5) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Brachytherapy, Radioimmunotherapy, Stereotactic Radiosurgery (SRS)

6) By Other Treatment Types: Gene Therapy, Stem Cell Transplantation, Metabolic Therapy, Nanomedicine

What Is Driving The Personalized Cancer Treatment Market? Surge In Cancer Prevalence Fuels Expansion Of Personalized Cancer Treatment Market

The increasing cancer prevalence is expected to propel the growth of the personalized cancer treatment market going forward. The rise in cancer is largely attributed to increasing life expectancy, which leads to more people reaching an age where cancer is more common and growing exposure to risk factors such as tobacco, alcohol, and obesity. Personalized cancer treatments provide targeted and effective therapies to manage diverse cancer types and stages, and this growing burden stimulates investment and innovation in precision medicine, aiming to improve patient outcomes through customized treatment plans. For instance, in February 2024, according to the World Health Organization, a Switzerland-based United Nations agency dedicated to global health and safety, the global cancer burden is projected to rise significantly, with an anticipated 77% increase in new cancer cases, reaching over 35 million by 2050 compared to 20 million in 2022. Therefore, increasing cancer prevalence is driving the growth of the personalized cancer treatment industry.

Who Are The Major Players In The Global Personalized Cancer Treatment Market?

Major companies operating in the personalized cancer treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Novartis AG, BioNTech SE, Illumina Inc., Artera, Exact Sciences Corporation., Moffitt Cancer Center, Myriad Genetics, NeoGenomics Laboratories, Guardant Health, Caris Life Sciences, Tempus AI Inc., Foundation Medicine, Immatics, Fate Therapeutics, CureVac AG, TScan Therapeutics, CureMetrix, PDC*line Pharma

What Are The Key Trends Of The Global Personalized Cancer Treatment Market? AI-Driven Analytics Revolutionizing Personalized Cancer Treatment

Major companies operating in the personalized cancer treatment market are focusing on developing innovative solutions, such as artificial intelligence (AI)-enabled multimodal immune profile algorithmic tests, to predict patient responses to immunotherapy and improve personalized treatment strategies. An AI-enabled multimodal immune profile algorithmic test analyzes multiple types of data, including genomic, transcriptomic, and clinical biomarkers, to assess a patient's immune profile and predict their response to immunotherapy to help stratify patients and guide personalized cancer treatments. For instance, in July 2024, Tempus AI, Inc., a US-based health technology company, launched its AI-enabled multimodal immune profile algorithmic test (IPS), marking its first offering in the immunotherapy diagnostics space. The test, available for research use only (RUO), assesses a range of immunotherapy-related biomarkers to generate a score that helps predict patient response to immunotherapy, supporting personalized cancer treatment. The AI-driven immunotherapy-focused diagnostics enhance patient stratification and treatment selection in oncology.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Personalized Cancer Treatment Market? Pfizer Acquires Seagen To Strengthen Oncology Portfolio

In December 2023, Pfizer Inc., a US-based pharmaceutical and biotechnology corporation, acquired Seagen Inc. for $43 billion. With this acquisition, Pfizer aims to leverage its cutting-edge antibody-drug conjugate technology, enhancing its capabilities in developing targeted cancer therapies. This strategic move aims to accelerate Pfizer's growth in the oncology market, addressing the urgent need for more effective cancer treatments. Seagen Inc. is a US-based biotechnology company focused on developing monoclonal antibody-based therapies for the treatment of cancer.

What Is The Regional Outlook For The Global Personalized Cancer Treatment Market?

North America was the largest region in the personalized cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized cancer treatment market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Personalized Cancer Treatment Market?

The personalized cancer treatment market consists of revenues earned by entities by providing services such as genetic testing, biomarker analysis, personalized therapy formulation, and targeted drug delivery. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized cancer treatment market also includes sales of products including targeted therapy drugs, genomic profiling kits, and companion diagnostics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Personalized Cancer Treatment Industry?

The personalized cancer treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the personalized cancer treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Personalized Cancer Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $200.98 billion
Revenue Forecast In 2034 $301.14 billion
Growth Rate CAGR of 10.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Treatment Type: Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type
2) By Diagnostic Techniques: Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types
4) By End-Users: Hospitals And Clinics, Research Institutes, Other End Users Subsegments: 1) By Targeted Therapy: Monoclonal Antibodies, Small Molecule Inhibitors, Angiogenesis Inhibitors, Signal Transduction Inhibitors
2) By Immunotherapy: Checkpoint Inhibitors, CAR T-Cell Therapy, Cancer Vaccines, Monoclonal Antibodies For Immunotherapy
3) By Hormone Therapy: Anti-Estrogens, Aromatase Inhibitors, Progestins, LHRH Agonists
4) By Chemotherapy: Alkylating Agents, Antimetabolites, Anthracyclines, Taxanes
5) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Brachytherapy, Radioimmunotherapy, Stereotactic Radiosurgery (SRS) 6) By Other Treatment Types: Gene Therapy, Stem Cell Transplantation, Metabolic Therapy, Nanomedicine
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Novartis AG, BioNTech SE, Illumina Inc., Artera, Exact Sciences Corporation., Moffitt Cancer Center, Myriad Genetics, NeoGenomics Laboratories, Guardant Health, Caris Life Sciences, Tempus AI Inc., Foundation Medicine, Immatics, Fate Therapeutics, CureVac AG, TScan Therapeutics, CureMetrix, PDC*line Pharma
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Personalized Cancer Treatment Market Characteristics

3. Personalized Cancer Treatment Market Trends And Strategies

4. Personalized Cancer Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Personalized Cancer Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Personalized Cancer Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Personalized Cancer Treatment Market Growth Rate Analysis

5.4. Global Personalized Cancer Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Personalized Cancer Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Personalized Cancer Treatment Total Addressable Market (TAM)

6. Personalized Cancer Treatment Market Segmentation

6.1. Global Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Targeted Therapy

Immunotherapy

Hormone Therapy

Chemotherapy

Radiation Therapy

Other Treatment Type

6.2. Global Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genomic Sequencing

Liquid Biopsy

Immunohistochemistry

In Situ Hybridization

Biomarker Testing

Other Diagnostic Techniques

6.3. Global Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Melanoma

Other Cancer Types

6.4. Global Personalized Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Research Institutes

Other End Users

6.5. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal Antibodies

Small Molecule Inhibitors

Angiogenesis Inhibitors

Signal Transduction Inhibitors

6.6. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Checkpoint Inhibitors

CAR T-Cell Therapy

Cancer Vaccines

Monoclonal Antibodies For Immunotherapy

6.7. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Hormone Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anti-Estrogens

Aromatase Inhibitors

Progestins

LHRH Agonists

6.8. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Alkylating Agents

Antimetabolites

Anthracyclines

Taxanes

6.9. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

External Beam Radiation Therapy (EBRT)

Brachytherapy

Radioimmunotherapy

Stereotactic Radiosurgery (SRS)

6.10. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Therapy

Stem Cell Transplantation

Metabolic Therapy

Nanomedicine

7. Personalized Cancer Treatment Market Regional And Country Analysis

7.1. Global Personalized Cancer Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Personalized Cancer Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Personalized Cancer Treatment Market

8.1. Asia-Pacific Personalized Cancer Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Personalized Cancer Treatment Market

9.1. China Personalized Cancer Treatment Market Overview

9.2. China Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Personalized Cancer Treatment Market

10.1. India Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Personalized Cancer Treatment Market

11.1. Japan Personalized Cancer Treatment Market Overview

11.2. Japan Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Personalized Cancer Treatment Market

12.1. Australia Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Personalized Cancer Treatment Market

13.1. Indonesia Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Personalized Cancer Treatment Market

14.1. South Korea Personalized Cancer Treatment Market Overview

14.2. South Korea Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Personalized Cancer Treatment Market

15.1. Western Europe Personalized Cancer Treatment Market Overview

15.2. Western Europe Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Personalized Cancer Treatment Market

16.1. UK Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Personalized Cancer Treatment Market

17.1. Germany Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Personalized Cancer Treatment Market

18.1. France Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Personalized Cancer Treatment Market

19.1. Italy Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Personalized Cancer Treatment Market

20.1. Spain Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Personalized Cancer Treatment Market

21.1. Eastern Europe Personalized Cancer Treatment Market Overview

21.2. Eastern Europe Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Personalized Cancer Treatment Market

22.1. Russia Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Personalized Cancer Treatment Market

23.1. North America Personalized Cancer Treatment Market Overview

23.2. North America Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Personalized Cancer Treatment Market

24.1. USA Personalized Cancer Treatment Market Overview

24.2. USA Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Personalized Cancer Treatment Market

25.1. Canada Personalized Cancer Treatment Market Overview

25.2. Canada Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Personalized Cancer Treatment Market

26.1. South America Personalized Cancer Treatment Market Overview

26.2. South America Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Personalized Cancer Treatment Market

27.1. Brazil Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Personalized Cancer Treatment Market

28.1. Middle East Personalized Cancer Treatment Market Overview

28.2. Middle East Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Personalized Cancer Treatment Market

29.1. Africa Personalized Cancer Treatment Market Overview

29.2. Africa Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Personalized Cancer Treatment Market Competitive Landscape And Company Profiles

30.1. Personalized Cancer Treatment Market Competitive Landscape

30.2. Personalized Cancer Treatment Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Personalized Cancer Treatment Market Other Major And Innovative Companies

31.1. Thermo Fisher Scientific Inc.

31.2. AstraZeneca Plc

31.3. Novartis AG

31.4. BioNTech SE

31.5. Illumina Inc.

31.6. Artera

31.7. Exact Sciences Corporation

31.8. Moffitt Cancer Center

31.9. Myriad Genetics

31.10. NeoGenomics Laboratories

31.11. Guardant Health

31.12. Caris Life Sciences

31.13. Tempus AI Inc.

31.14. Foundation Medicine

31.15. Immatics

32. Global Personalized Cancer Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Personalized Cancer Treatment Market

34. Recent Developments In The Personalized Cancer Treatment Market

35. Personalized Cancer Treatment Market High Potential Countries, Segments and Strategies

35.1 Personalized Cancer Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Personalized Cancer Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Personalized Cancer Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Personalized Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Hormone Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Personalized Cancer Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Personalized Cancer Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Pfizer Inc. Financial Performance
  • Table 82: Johnson & Johnson Financial Performance
  • Table 83: F. Hoffmann-La Roche Financial Performance
  • Table 84: Merck & Co. Inc. Financial Performance
  • Table 85: Bristol Myers Squibb Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Personalized Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Hormone Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Personalized Cancer Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Personalized Cancer Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Personalized Cancer Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Pfizer Inc. Financial Performance
  • Figure 82: Johnson & Johnson Financial Performance
  • Figure 83: F. Hoffmann-La Roche Financial Performance
  • Figure 84: Merck & Co. Inc. Financial Performance
  • Figure 85: Bristol Myers Squibb Company Financial Performance

Latest Market Developments in Ketamine Clinic Industry: Forecast 2025–2029

Read More About Latest Market Developments in Ketamine Clinic Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Lifestyle Diseases Apps Industry Through 2029

Read More About Competitive and Market Trend Analysis of Lifestyle Diseases Apps Industry Through 2029

Industry Trends Show Locum Tenens Staffing Market Set to Expand at 11.6% CAGR Until 2029

Read More About Industry Trends Show Locum Tenens Staffing Market Set to Expand at 11.6% CAGR Until 2029

In-Depth Lung Cancer Surgery Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Lung Cancer Surgery Market Report: Business Trends, Growth Factors, and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

View Report

Automotive Smart Key Global Market Report 2025 – By Type (Passive Key Less Access, Remote Key Less Access), By Installation (OEM, After Market), By Application (Single Function, Multi-Function) – Impact of Tariff and Tra...

View Report

Laboratory Refrigerators And Ovens Global Market Report 2025 – By Laboratory Refrigerators (General Purpose Lab Refrigerator, Explosion Proof Refrigerator, Portable Refrigerator, Sub-Zero Refrigerator, Walk-In Refrigerat...

View Report

Colorectal Cancer Drugs Global Market Report 2025 – By Type (Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL...

View Report

Skin Care Stores Global Market Report 2025 – By Product Type (Facial Care, Lip Care, Body Care), By Packaging Type (Tubes, Jars, Bottles), By Category (Premium Skin Care Products, Mass Skin Care Products), By Gender (Fem...

View Report

Peptide And Oligonucleotide CDMO Global Market Report 2025 – By Product (Peptides, Oligonucleotides), By Service Type (Contract Development, Contract Manufacturing,), By Application (Therapeutics, Research Applications, ...

View Report

Acai Berry Global Market Report 2025 – By Product (Pulp, Dried), By Distribution Channel (Hypermarket, Supermarket, Online Stores, Convenience Stores), By Application (Food And Beverages, Pharmaceuticals, Dietary Supplem...

View Report

Hydroelectric Cells Global Market Report 2025 – By Metal Oxide (Tin (IV) Oxide (SnO, Aluminum Oxide (AI2O, Zinc Oxide (ZnO), Titanium Dioxide (TiO, Magnesium Oxide (MgO), Silicon Dioxide (SiO,), By Application (Portable ...

View Report

Frequently Asked Questions

Personalized cancer treatment customizes therapies based on an individual's unique genetic profile and tumor characteristics, to achieve more effective and targeted interventions. This approach enhances treatment plans and improves patient outcomes by examining genetic mutations and biomarkers, compared to traditional one-size-fits-all methods. For further insights on this market, request a sample here

The market major growth driver - Surge In Cancer Prevalence Fuels Expansion Of Personalized Cancer Treatment Market. For further insights on this market, request a sample here

The personalized cancer treatment market size has grown rapidly in recent years. It will grow from $181.55 billion in 2024 to $200.98 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to advancements in genomics and molecular biology, increasing prevalence of cancer, a rise in personalized medicine adoption, growing awareness about cancer treatment options, and improved cancer diagnostics and monitoring technologies. The personalized cancer treatment market size is expected to see rapid growth in the next few years. It will grow to " $301.14 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to the expansion of targeted therapies, advancements in AI and machine learning for treatment planning, increasing investment in cancer research, growing demand for precision medicine, and the development of new biomarkers for personalized treatments. Major trends in the forecast period include the rising use of combination therapies, increased integration of digital health tools, growth in the adoption of liquid biopsy techniques, expansion of immunotherapy options, and enhanced focus on patient-centric care models. For further insights on this market, request a sample here

The personalized cancer treatmentmarket covered in this report is segmented –
1) By Treatment Type: Targeted Therapy; Immunotherapy; Hormone Therapy; Chemotherapy; Radiation Therapy; Other Treatment Type
2) By Diagnostic Techniques: Genomic Sequencing; Liquid Biopsy; Immunohistochemistry; In Situ Hybridization; Biomarker Testing; Other Diagnostic Techniques
3) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Melanoma; Other Cancer Types
4) By End-Users: Hospitals And Clinics; Research Institutes; Other End Users Subsegments:
1) By Targeted Therapy: Monoclonal Antibodies; Small Molecule Inhibitors; Angiogenesis Inhibitors; Signal Transduction Inhibitors
2) By Immunotherapy: Checkpoint Inhibitors; CAR T-Cell Therapy; Cancer Vaccines; Monoclonal Antibodies For Immunotherapy
3) By Hormone Therapy: Anti-Estrogens; Aromatase Inhibitors; Progestins; LHRH Agonists
4) By Chemotherapy: Alkylating Agents; Antimetabolites; Anthracyclines; Taxanes
5) By Radiation Therapy: External Beam Radiation Therapy (EBRT); Brachytherapy; Radioimmunotherapy; Stereotactic Radiosurgery (SRS)
6) By Other Treatment Types: Gene Therapy; Stem Cell Transplantation; Metabolic Therapy; Nanomedicine For further insights on this market, request a sample here

North America was the largest region in the personalized cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the personalized cancer treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Novartis AG, BioNTech SE, Illumina Inc., Artera, Exact Sciences Corporation., Moffitt Cancer Center, Myriad Genetics, NeoGenomics Laboratories, Guardant Health, Caris Life Sciences, Tempus AI Inc., Foundation Medicine, Immatics, Fate Therapeutics, CureVac AG, TScan Therapeutics, CureMetrix, PDC*line Pharma . For further insights on this market, request a sample here.

Major trends in this market include AI-Driven Analytics Revolutionizing Personalized Cancer Treatment. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Personalized Cancer Treatment Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon